RSS   Newsletter   Contact   Advertise with us
Post Online Media
Post Online Media Magazine

Maxygen announces management changes

Share on Twitter Share on LinkedIn
Staff writer | Redwood City, Ca., USA | September 29, 2009
MaxygenMaxygen, Inc., a biopharmaceutical company, announced that James Sulat, who currently serves as a director of the company, has been appointed to serve as chief executive officer, effective October 1.
Mr. Sulat has served as a director since October 2003.

Since February 2008, Mr. Sulat has served as the Chief Financial Officer of Memory Pharmaceuticals Corp., a biotechnology company.

From May 2005 to February 2008, Mr. Sulat served as Chief Executive Officer of Memory Pharmaceuticals Corp.

Mr. Sulat was Senior Executive Vice President and Interim Chief Financial Officer of R.R. Donnelley & Sons Co., a diversified printing company, from February 2004 until May 2004.

From April 2003 to February 2004, Mr. Sulat was Senior Executive Vice President of Moore Wallace Incorporated, a diversified printing company that was acquired by R.R. Donnelley in 2004.

From April 1998 to April 2003, Mr. Sulat was Vice President and Chief Financial Officer of Chiron Corporation, a biotechnology company.

Mr. Sulat is also a director of Intercell AG, a developer of vaccines for the prevention and treatment of major infectious diseases that is listed on the Vienna Stock Exchange.

Mr. Sulat holds a B.S. from Yale University, an M.B.A. from Stanford University and an M.S. in health services administration from Stanford University.

Mr. Sulat will replace Russell Howard, who has served as Maxygen’s Chief Executive Officer and as a director since June 1998.

Dr. Howard will be leaving his positions as an officer and director of Maxygen on September 30, 2009.

Larry Briscoe, Maxygen's Chief Financial Officer, will also be departing the company on September 30, 2009.

In addition to his role as Chief Executive Officer, Mr. Sulat will also assume the role of Chief Financial Officer and will continue to serve on Maxygen’s Board of Directors.


POST Online Media Contact